Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Controlled Study of Rigosertib Versus Physician's Choice of Treatment in MDS Patients After Failure of an HMA (INSPIRE)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT02562443
Recruitment Status : Active, not recruiting
First Posted : September 29, 2015
Last Update Posted : June 23, 2020
Sponsor:
Information provided by (Responsible Party):
Onconova Therapeutics, Inc.

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Active, not recruiting
Estimated Primary Completion Date : December 31, 2020
Estimated Study Completion Date : December 31, 2021